In Malaysia, cervical cancer is the third most common cancer (National Cancer Society Malaysia, 2019). Every year, approximately 2,000 Malaysian women are diagnosed with cervical cancer.
The leading cause of cervical cancer is persistent infection with the Human Papillomavirus (HPV). HPV infection is related to 99% of cervical cancer cases. High-risk HPV subtypes alone (HPV-16 and HPV -18) have been identified to be the cause of at least 70% of cervical cancer (World Health Organization, 2019).
Cervical cancer develops from the abnormal cells of the cervix. It is usually due to persistent Human Papillomavirus (HPV) infection and cellular damage to healthy cells.
Before cervical cancer develops, the disease has a window of opportunity, whereby abnormal cervical cells (pre-cancerous cells) from persistent HPV infection and cellular damage, takes 5 -10 years before they finally become cancerous cells. When cancer progresses, it starts to invade and spread to other organs of our body (brain, lungs, abdomen and pelvic organs).
Most of the time, cervical cancer has no clinical symptoms. The presence of clinical signs and symptoms usually suggest that cervical cancer is at an advanced stage. Hence, it is vital for women to have regular cervical smear tests or Pap tests so that the disease can be detected early or even at the Pre-Cancerous Stage.
Nevertheless, women should consult their doctor if they are experiencing symptoms such as:
- Post-menopausal bleeding
- Post-coital bleeding
- Abnormal bleeding in between periods
- Unusual vaginal discharge
- Pelvic and abdominal pain
Cervical cancer is a preventable disease. Indeed, no one should die from cervical cancer.
Education, awareness and regular Pap Smear are the main steps for cervical cancer prevention. Besides, the HPV vaccine is available to boost our immunity and prevent persistent HPV infection in women.
Unfortunately, most women are not aware of the importance of getting screened as well as getting the HPV vaccination.
Cervical Screening Package
In conjunction of International Women’s Day, Beacon Hospital is offering a Cervical Screening package for women aged 21 – 65 years old, at a subsidized rate.
This package cost only RM150 and includes the following:
- Gynaecology Specialist Consultation
- Liquid-based (Surepath) Pap smear
- Pelvic Ultrasound Scan (Transvaginal)
- One Complementary Outpatient Follow Up
Terms & Conditions:
- This CSR programme is valid from 8th March 2021 to 30th August 2021.
- This CSR programme is applicable for females aged 21 years old and above.
- This CSR programme is limited to the first 300 customers only.
- The CSR programme includes Liquid-based (Surepath) Pap smear, Gynae Specialist Consultation and Transvaginal Ultrasound Screening.
- This CSR programme excludes registration fee and other additional tests/ medications/ procedures.
- This CSR programme is valid for self-pay patient only.
- Customers are required to make prior appointment for the screening.
- Beacon Hospital reserves the right to change the terms & conditions anytime without prior notice.